CIK 0002114044 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Hemab Therapeutics Holdings, Inc.
Sign in to watch- Ticker
- COAG
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 414241952
- Phone
- 45 2138 7627
- Business address
- 101 MAIN STREET, SUITE 1220, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-24 | Walbert Keli Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2026-06-16 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Purchase | +61,523 | $24.98 | $1.5M | 6,444,637 |
| 2026-06-15 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Purchase | +6,146 | $24.89 | $153K | 6,383,114 |
| 2026-05-20 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Purchase | +996 | $24.94 | $25K | 6,376,968 |
| 2026-05-19 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Purchase | +3,802 | $24.97 | $95K | 6,375,972 |
| 2026-05-12 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Purchase | +6,387 | $24.90 | $159K | 6,372,170 |
| 2026-05-11 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Purchase | +14,149 | $24.47 | $346K | 6,340,063 |
| 2026-05-11 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Purchase | +25,720 | $25.00 | $643K | 6,365,783 |
| 2026-05-08 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Purchase | +1,483 | $24.98 | $37K | 6,325,914 |
| 2026-05-07 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Purchase | +7,921 | $24.34 | $193K | 6,322,446 |
| 2026-05-07 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Purchase | +1,985 | $24.95 | $50K | 6,324,431 |
| 2026-05-06 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +14,611 | $23.77 | $347K | 6,261,118 |
| 2026-05-06 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +53,407 | $24.83 | $1.3M | 6,314,525 |
| 2026-05-05 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +87,143 | $24.59 | $2.1M | 6,236,239 |
| 2026-05-05 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +10,268 | $25.00 | $257K | 6,246,507 |
| 2026-05-04 | Novo Holdings A/S 10% owner | Conversion | +4,180,550 | 4,180,550 | ||
| 2026-05-04 | Novo Holdings A/S 10% owner | Conversion · Series Seed Preferred Stock | −23,343 | 0 | ||
| 2026-05-04 | Novo Holdings A/S 10% owner | Conversion · Series A Preferred Stock | −71,866 | 0 | ||
| 2026-05-04 | Novo Holdings A/S 10% owner | Conversion · Series B Preferred Stock | −62,121 | 0 | ||
| 2026-05-04 | Novo Holdings A/S 10% owner | Conversion · Series C Preferred Stock | −32,695 | 0 |
Page 1 of 2 · 40 trades